Lifecore Biomedical Files 8-K

Ticker: LFCR · Form: 8-K · Filed: Aug 12, 2025 · CIK: 1005286

Lifecore Biomedical, Inc. \De\ 8-K Filing Summary
FieldDetail
CompanyLifecore Biomedical, Inc. \De\ (LFCR)
Form Type8-K
Filed DateAug 12, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k

TL;DR

Lifecore Biomedical filed an 8-K on Aug 12, 2025. Check for updates.

AI Summary

On August 12, 2025, Lifecore Biomedical, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.

Why It Matters

This filing indicates Lifecore Biomedical, Inc. is providing updates or disclosures to the SEC, which could contain important information for investors.

Risk Assessment

Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain specific material events or financial data that would indicate a change in risk.

Key Players & Entities

  • Lifecore Biomedical, Inc. (company) — Registrant
  • August 12, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of incorporation
  • Chaska, Minnesota (location) — Principal executive offices

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.

What is the exact name of the registrant?

The exact name of the registrant is Lifecore Biomedical, Inc.

In which state was Lifecore Biomedical, Inc. incorporated?

Lifecore Biomedical, Inc. was incorporated in Delaware.

What is the address of Lifecore Biomedical, Inc.'s principal executive offices?

The address of Lifecore Biomedical, Inc.'s principal executive offices is 3515 Lyman Boulevard, Chaska, Minnesota 55318.

What is the IRS Employer Identification Number for Lifecore Biomedical, Inc.?

The IRS Employer Identification Number for Lifecore Biomedical, Inc. is 94-3025618.

Filing Stats: 526 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2025-08-12 07:53:33

Key Financial Figures

  • $0.001 — ich registered Common stock, par value $0.001 per share LFCR The NASDAQ Global Select

Filing Documents

01 Regulation FD

Item 7.01 Regulation FD. Beginning on August 12, 2025, Lifecore Biomedical, Inc. (the "Company") intends to use a presentation (the "Presentation") in discussions with certain of its investors, analysts and others. A copy of the Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference in this Item 7.01. A copy of the presentation will be furnished at, and posted on, the Company's website (https://ir.lifecore.com/events-presentations). The information furnished in this Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Lifecore Biomedical Presentation dated August 12, 2025 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 12, 2025 LIFECORE BIOMEDICAL, INC. By: /s/ Ryan D. Lake Ryan D. Lake Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.